Adenosine Contrast CorrELations in Evaluating RevAscularizaTION
Summary
The purpose of this study is to compare FFR measurements done with adenosine to FFR measurements done with contrast, where the contrast is injected using the ACIST CVi automated contrast injector. The ACCELERATION study will support a safer approach to FFR for patients by potentially reducing toxic drug exposure (adenosine). The 2 main objectives of the study are: 1. Perform a methods comparison between cFFR and the reference standard aFFR, where cFFR is performed using an automated injector with a standardized volume and rate of delivery of contrast with known osmolality. 2. Evaluate the association between final post-PCI FFR and long-term clinical outcomes. The long-term clinical outcomes will include TVR and composite MACE (death, MI, and TVR) at 30 days and 1 year.
Timeline
- Start
- 2019-01-17
- Primary completion
- 2022-05-04
- Completion
- 2023-04-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adenosine | Small molecule | 140 ug/kg | Intravenous |
| Subject | Iopamidol | Diagnostic / imaging agent | 6 ml | Other |
| Subject | Iopamidol | Diagnostic / imaging agent | 10 ml | Other |
Indications
No indication recorded.